Skip to main content
. 2017 Jul 4;8(63):106486–106498. doi: 10.18632/oncotarget.18984

Figure 4. Remarkable inhibition of PI3K/AKT/mTOR signaling of SCLC cells by RAD001 and BEZ235 co-treatment.

Figure 4

SCLC cells (H82, H526, DMS79 and H446) were treated with DMSO control, RAD001 (10 nM), BEZ235 (10 nM) or the combination of RAD001 (10 nM) and BEZ235 (10 nM) for 12 hr. Cellular proteins were collected for western blot. D: DMSO, B: BEZ235, R: RAD001, B+R: BEZ235+RAD001.